SN 2009ip at late times - an interacting transient at+2 years

We present photometric and spectroscopic observations of the interacting transient SN 2009ip taken during the 2013 and 2014 observing seasons. We characterize the photometric evolution as a steady and smooth decline in all bands, with a decline rate that is slower than expected for a solely Co-56-powered supernova at late phases. No further outbursts or eruptions were seen over a two year period from 2012 December until 2014 December. SN 2009ip remains brighter than its historic minimum from pre-discovery images. Spectroscopically, SN 2009ip continues to be dominated by strong, narrow (less than or similar to 2000 km s(-1)) emission lines of H, He, Ca, and Fe. While we make tenuous detections of [Fe II] lambda 7155 and [O I] lambda lambda 6300, 6364 lines at the end of 2013 June and the start of 2013 October, respectively, we see no strong broad nebular emission lines that could point to a core-collapse origin. In general, the lines appear relatively symmetric, with the exception of our final spectrum in 2014 May, when we observe the appearance of a redshifted shoulder of emission at +550 km s(-1). The lines are not blueshifted, and we see no significant near-or mid-infrared excess. From the spectroscopic and photometric evolution of SN 2009ip until 820 d after the start of the 2012a event, we still see no conclusive evidence for core-collapse, although whether any such signs could be masked by ongoing interaction is unclear.

Precision dating of the Palaeolithic: A new radiocarbon chronology for the Abri Pataud (France), a key Aurignacian sequence

This paper presents a new series of AMS dates on ultrafiltered bone gelatin extracted from identified cutmarked or humanly-modified bones and teeth from the site of Abri Pataud, in the French Dordogne. The sequence of 32 new determinations provides a coherent and reliable chronology from the site's early Upper Palaeolithic levels 5-14, excavated by Hallam Movius. The results show that there were some problems with the previous series of dates, with many underestimating the real age. The new results, when calibrated and modelled using a Bayesian statistical method, allow detailed understanding of the pace of cultural changes within the Aurignacian I and II levels of the site, something not achievable before. In the future, the sequence of dates will allow wider comparison to similarly dated contexts elsewhere in Europe. High precision dating is only possible by using large suites of AMS dates from humanly-modified material within well understood archaeological sequences modelled using a Bayesian statistical method. © 2011.

MErCuRIC1: A Phase I study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor crizotinib in RASMT and RASWT (with aberrant c-MET) metastatic colorectal cancer (mCRC) patients.

Background: RAS is mutated (RASMT) in ~55% of mCRC, and phase III studies have shown that patients harbouring RAS mutations do not benefit from anti-EGFR MoAbs. In addition, ~50% of RAS Wild Type (RASWT) will not benefit from the addition of an EGFR MoAb to standard chemotherapy. Hence, novel treatment strategies are urgently needed for RASMT and > 50% of RASWT mCRC patients. c-MET is overexpressed in ~50-60%, amplified in ~2-3% and mutated in ~3-5% of mCRC. Recent preclinical studies have shown that c-MET is an important mediator of resistance to MEK inhibitors (i) in RASMT mCRC, and that combined MEKi/METi resulted in synergistic reduction in tumour growth in RASMT xenograft models (1). A number of recent studies have highlighted the role of c-MET in mediating primary/secondary resistance to anti-EGFR MoAbs in mCRC, suggesting that patient with RASWT tumours with aberrant c-MET (RASWT/c-MET+) may benefit from anti-c-MET targeted therapies (2). These preclinical data supported the further clinical evaluation of combined MEKi/METi treatment in RASMT and RASWT CRC patients with aberrant c-MET signalling (overexpression, amplification or mutation; RASWT/c-MET+). Methods: MErCuRIC1 is a phase I combination study of METi crizotinib with MEKi PD-0325901. The dose escalation phase, utilizing a rolling six design, recruits 12-24 patients with advanced solid tumours and aims to assess safety/toxicity of combination, recommended phase II (RPII) dose, pharmacokinetics (PK) and pharmacodynamics (PD) (pERK1/2 in PBMC and tumour; soluble c-MET). In the dose expansion phase an additional 30-42 RASMT and RASWT/c-MET mCRC patients with biopsiable disease will be treated at the RPII dose to further evaluate safety, PK, PD and treatment response. In the dose expansion phase additional biopsy and blood samples will be obtained to define mechanisms of response/resistance to crizotinib/PD-0325901 therapy. Enrolment into the dose escalation phase began in December 2014 with cohort 1 still ongoing. EudraCT registry number: 2014-000463-40. (1) Van Schaeybroeck S et al. Cell Reports 2014;7(6):1940-55; (2) Bardelli A et al. Cancer Discov 2013;3(6):658-73. Clinical trial information: 2014-000463-40.

Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries

Importance Limited information exists about the epidemiology, recognition, management, and outcomes of patients with the acute respiratory distress syndrome (ARDS).

Objectives To evaluate intensive care unit (ICU) incidence and outcome of ARDS and to assess clinician recognition, ventilation management, and use of adjuncts—for example prone positioning—in routine clinical practice for patients fulfilling the ARDS Berlin Definition.

Design, Setting, and Participants The Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) was an international, multicenter, prospective cohort study of patients undergoing invasive or noninvasive ventilation, conducted during 4 consecutive weeks in the winter of 2014 in a convenience sample of 459 ICUs from 50 countries across 5 continents.

Exposures Acute respiratory distress syndrome.

Main Outcomes and Measures The primary outcome was ICU incidence of ARDS. Secondary outcomes included assessment of clinician recognition of ARDS, the application of ventilatory management, the use of adjunctive interventions in routine clinical practice, and clinical outcomes from ARDS.

Results Of 29 144 patients admitted to participating ICUs, 3022 (10.4%) fulfilled ARDS criteria. Of these, 2377 patients developed ARDS in the first 48 hours and whose respiratory failure was managed with invasive mechanical ventilation. The period prevalence of mild ARDS was 30.0% (95% CI, 28.2%-31.9%); of moderate ARDS, 46.6% (95% CI, 44.5%-48.6%); and of severe ARDS, 23.4% (95% CI, 21.7%-25.2%). ARDS represented 0.42 cases per ICU bed over 4 weeks and represented 10.4% (95% CI, 10.0%-10.7%) of ICU admissions and 23.4% of patients requiring mechanical ventilation. Clinical recognition of ARDS ranged from 51.3% (95% CI, 47.5%-55.0%) in mild to 78.5% (95% CI, 74.8%-81.8%) in severe ARDS. Less than two-thirds of patients with ARDS received a tidal volume 8 of mL/kg or less of predicted body weight. Plateau pressure was measured in 40.1% (95% CI, 38.2-42.1), whereas 82.6% (95% CI, 81.0%-84.1%) received a positive end-expository pressure (PEEP) of less than 12 cm H2O. Prone positioning was used in 16.3% (95% CI, 13.7%-19.2%) of patients with severe ARDS. Clinician recognition of ARDS was associated with higher PEEP, greater use of neuromuscular blockade, and prone positioning. Hospital mortality was 34.9% (95% CI, 31.4%-38.5%) for those with mild, 40.3% (95% CI, 37.4%-43.3%) for those with moderate, and 46.1% (95% CI, 41.9%-50.4%) for those with severe ARDS.

Conclusions and Relevance Among ICUs in 50 countries, the period prevalence of ARDS was 10.4% of ICU admissions. This syndrome appeared to be underrecognized and undertreated and associated with a high mortality rate. These findings indicate the potential for improvement in the management of patients with ARDS.

Ferroelectric Vortices and Related Configurations

This chapter discusses that the theoretical studies, using both atomistic and phenomenological approaches, have made clear predictions about the existence and behaviour of ferroelectric (FE) vortices. Effective Hamiltonians can be implemented within both Monte Carlo (MC) and molecular dynamics (MD) simulations. In contrast to the effective Hamiltonian method, which is atomistic in nature, the phase field method employs a continuum approach, in which the polarization field is the order parameter. Properties of FE nanostructures are largely governed by the existence of a depolarization field, which is much stronger than the demagnetization field in magnetic nanosystems. The topological patterns seen in rare earth manganites are often referred to as vortices and yet this claim never seems to be explicitly justified. By inspection, the form of a vortex structure is such that there is a continuous rotation in the orientation of dipole vectors around the singularity at the centre of the vortex.

F. G. Teixeira e a comunidade matemática europeia nos séculos XIX-XX

Esta dissertação descreve o processo de integração dos matemáticos portugueses na comunidade matemática internacional no final do século XIX e início do século XX, focando-se na vida e obra do matemático Francisco Gomes Teixeira (1851-1933). Tenciona a ser mais um contributo para o reconhecimento nacional e internacional do matemático Gomes Teixeira analisando a sua obra como matemático e organizador científico em Portugal através de fontes, parcialmente ainda não conhecidas. Para esse efeito analisou-se a evolução histórica que ocorreu no mundo científico daquela época, em particular a formação da comunidade matemática através de iniciativas individuais ou coletivas, muitas vezes acompanhadas pela fundação de revistas e elaboração de manuais que contribuíram para a internacionalização e, de certa forma, para uma estandardização do estudo universitário básico. Em particular foi estudada a situação em Portugal, onde o papel de liderança foi assumido por Gomes Teixeira. Mostra-se como Gomes Teixeira, graças ao seu trabalho, ao seu talento como matemático e à sua atividade como organizador académico, conseguiu reduzir significativamente o isolamento científico de Portugal na área da matemática. Estudou-se em extensão a fundação de revistas científicas em diferentes países, acompanhando a sua evolução desde de revistas nacionais até revistas internacionais. Focando-nos no Jornal de Sciencias Matemáticas e Astronómicas, fundado em 1877 por Gomes Teixeira (mais tarde conhecido internacionalmente como Teixeira’s Journal), acompanhamos detalhadamente a sua transformação de uma revista nacional numa revista internacional, sendo esta transformação comum naquela época à maioria de revistas científicas importantes de outros países como, por exemplo, no caso do Jornal de Crelle, do Jornal de Liouville, ou outros. Estudou-se igualmente o reconhecimento a nível internacional, através de referências estrangeiras, da abordagem original de Gomes Teixeira à Análise Infinitesimal patente nos seus manuais. O interesse de Gomes Teixeira pela teoria das funções analíticas e pelos seus diferentes desenvolvimentos em série manifestou-se no grande número de artigos publicados sobre este tema e encontrou reconhecimento justo pela designação de um teorema que completa resultados de Lagrange e de Laurent como Teorema de Teixeira. Na sua análise do mérito científico de Gomes Teixeira esta dissertação restringiu-se conscientemente nesta área da Análise Matemática, uma vez que um estudo abrangente de toda a obra ultrapassasse o nosso objetivo. Foi também discutido o intenso intercâmbio científico levado a cabo por Gomes Teixeira através de correspondência e troca de publicações ou permuta de revistas com os matemáticos de diferentes países. Esta análise permitiu verificar um aumento da popularidade dos matemáticos portugueses através do incremento do número de artigos publicados no estrangeiro durante quase 30 anos. Uma fonte imprescindível nesta análise foi o Jahrbuch über die Fortschritte der Mathematik, cujas referências (em geral na língua alemã e por isso até agora quase nunca usadas na literatura Portuguesa) documentaram as publicações em quase todas as revistas matemáticas durante os anos da sua existência entre 1868 e 1942. Descreve-se a colaboração de Gomes Teixeira com diferentes organizações internacionais e documenta-se o apreço internacional por parte do mundo académico. Novos documentos traçam o processo de eleição como membro da Academia das Ciências Alemã Leopoldina, sob proposta de Georg Cantor e outros matemáticos alemães. Finalmente, incluí-se uma breve descrição das atividades levadas a cabo na Rússia, em Espanha e na Grécia em prol do processo de internacionalização da comunidade matemática europeia tendo em vista uma melhor contextualização do contributo de Gomes Teixeira para a integração de Portugal neste processo.

The PREDICTS database: a global database of how local terrestrial biodiversity responds to human impacts

Biodiversity continues to decline in the face of increasing anthropogenic pressures such as habitat destruction, exploitation, pollution and introduction of alien species. Existing global databases of species’ threat status or population time series are dominated by charismatic species. The collation of datasets with broad taxonomic and biogeographic extents, and that support computation of a range of biodiversity indicators, is necessary to enable better understanding of historical declines and to project – and avert – future declines. We describe and assess a new database of more than 1.6 million samples from 78 countries representing over 28,000 species, collated from existing spatial comparisons of local-scale biodiversity exposed to different intensities and types of anthropogenic pressures, from terrestrial sites around the world. The database contains measurements taken in 208 (of 814) ecoregions, 13 (of 14) biomes, 25 (of 35) biodiversity hotspots and 16 (of 17) megadiverse countries. The database contains more than 1% of the total number of all species described, and more than 1% of the described species within many taxonomic groups – including flowering plants, gymnosperms, birds, mammals, reptiles, amphibians, beetles, lepidopterans and hymenopterans. The dataset, which is still being added to, is therefore already considerably larger and more representative than those used by previous quantitative models of biodiversity trends and responses. The database is being assembled as part of the PREDICTS project (Projecting Responses of Ecological Diversity In Changing Terrestrial Systems – www.predicts.org.uk). We make site-level summary data available alongside this article. The full database will be publicly available in 2015.

Les stratégies de raisonnement à travers des problèmes statistiques et de proportionnalité chez des élèves du 3e cycle du primaire

Dans le cadre de notre mémoire, nous avons comme objectif de décrire et de comprendre comment le contexte statistique, avec son caractère quasi-proportionnel, influence le raisonnement chez les élèves au 3e cycle du primaire. D'abord, nous développons quatre problèmes. En résolvant ces problèmes, les élèves d'une classe du 3e cycle du primaire fourniront un aperçu de leur raisonnement proportionnel et statistique et des stratégies qu'ils utilisent pour la résolution de ces tâches qui favorisent un traitement statistique ou proportionnel. Le chapitre 1 de notre mémoire sert à présenter la problématique de la recherche. Ensuite, le chapitre 2 concerne le cadre conceptuel et les questions spécifiques de la recherche. Le chapitre 3 expose les considérations de la méthodologie, notamment de la description des tâches, de l'analyse et du traitement des données. Par la suite, dans le chapitre 4, nous présentons et analyserons nos données. Finalement, dans les chapitres 5 et 6, la discussion des résultats sert à mettre en relation des principaux résultats de la présente recherche. Aussi, quelques pistes à poursuivre dans d'autres recherches sont suggérées.

Effets de la salinité sur le développement de la canneberge

De nouvelles recommandations dans la production de canneberges suggèrent l’utilisation de l’irrigation souterraine, une méthode susceptible d’augmenter l’accumulation de sels dans le sol. Par ailleurs, le prélèvement d’eaux souterraines saumâtres dans des nappes résiduelles de la mer Champlain sous les dépôts d’argile dans la vallée du St-Laurent ou résultant du rehaussement des niveaux marins dans les zones côtières dû aux changements climatiques pourrait affecter la productivité des canneberges cultivées dans l’Est du Canada. Puisque très peu de données concernant la tolérance de la canneberge à la salinité sont disponibles, cette étude a été menée afin de déterminer si ces nouvelles recommandations pourraient éventuellement affecter le rendement de la plante. Dans une serre, des plants de canneberge ont été soumis à huit traitements obtenus à partir de deux méthodes d’irrigation (aspersion et irrigation souterraine) et quatre niveaux de salinité créés par des quantités croissantes de K2SO4 (125, 2 500, 5 000 et 7 500 kg K2O ha-1). L’irrigation souterraine a entraîné des conditions édaphiques plus sèches. Cependant, aucune différence significative de la conductivité électrique de la solution du sol (CEss) n’a été observée entre les deux types d’irrigation. Pourtant, les taux de photosynthèse et la nouaison étaient significativement plus faibles chez les plantes sous traitement d’irrigation souterraine. Les paramètres de croissance ont diminué de façon linéaire avec l’augmentation de la salinité alors que les paramètres de rendement ont connu une diminution quadratique avec l’élévation de la CEss. Une CEss moyenne de 3,2 dS m-1 pendant la floraison a provoqué une chute de 22% du taux relatif de photosynthèse et une diminution de 56% du rendement par rapport au témoin. Le suivi de la conductivité électrique du sol lors de l’implantation d’une régie d’irrigation souterraine de déficit en production de canneberges serait donc recommandable afin d’éviter le stress salin.

Pharmacokinetics and pharmacogenomics of once-daily raltegravir and atazanavir in healthy volunteers.

Atazanavir inhibits UDP-glucuronyl-transferase-1A1 (UGT1A1), which metabolizes raltegravir, but the magnitude of steady-state inhibition and role of the UGT1A1 genotype are unknown. Sufficient inhibition could lead to reduced-dose and -cost raltegravir regimens. Nineteen healthy volunteers, age 24 to 51 years, took raltegravir 400 mg twice daily (arm A) and 400 mg plus atazanavir 400 mg once daily (arm B), separated by ?3 days, in a crossover design. After 1 week on each regimen, raltegravir and raltegravir-glucuronide plasma and urine concentrations were measured by liquid chromatography-tandem mass spectrometry in multiple samples obtained over 12 h (arm A) or 24 h (arm B) and analyzed by noncompartmental methods. UGT1A1 promoter variants were detected with a commercially available kit and published primers. The primary outcome was the ratio of plasma raltegravir C(tau), or concentration at the end of the dosing interval, for arm B (24 h) versus arm A (12 h). The arm B-to-arm A geometric mean ratios (95% confidence interval, P value) for plasma raltegravir C(tau), area under the concentration-time curve from 0 to 12 h (AUC(0-12)), and raltegravir-glucuronide/raltegravir AUC(0-12) were 0.38 (0.22 to 0.65, 0.001), 1.32 (0.62 to 2.81, 0.45), and 0.47 (0.38 to 0.59, <0.001), respectively. Nine volunteers were heterozygous and one was homozygous for a UGT1A1 reduction-of-function allele, but these were not associated with metabolite formation. Although atazanavir significantly reduced the formation of the glucuronide metabolite, its steady-state boosting of plasma raltegravir did not render the C(tau) with a once-daily raltegravir dose of 400 mg similar to the C(tau) with the standard twice-daily dose. UGT1A1 promoter variants did not significantly influence this interaction.

Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial.

BACKGROUND AND OBJECTIVES: The SBP values to be achieved by antihypertensive therapy in order to maximize reduction of cardiovascular outcomes are unknown; neither is it clear whether in patients with a previous cardiovascular event, the optimal values are lower than in the low-to-moderate risk hypertensive patients, or a more cautious blood pressure (BP) reduction should be obtained. Because of the uncertainty whether 'the lower the better' or the 'J-curve' hypothesis is correct, the European Society of Hypertension and the Chinese Hypertension League have promoted a randomized trial comparing antihypertensive treatment strategies aiming at three different SBP targets in hypertensive patients with a recent stroke or transient ischaemic attack. As the optimal level of low-density lipoprotein cholesterol (LDL-C) level is also unknown in these patients, LDL-C-lowering has been included in the design. PROTOCOL DESIGN: The European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment trial is a prospective multinational, randomized trial with a 3 × 2 factorial design comparing: three different SBP targets (1, <145-135; 2, <135-125; 3, <125 mmHg); two different LDL-C targets (target A, 2.8-1.8; target B, <1.8 mmol/l). The trial is to be conducted on 7500 patients aged at least 65 years (2500 in Europe, 5000 in China) with hypertension and a stroke or transient ischaemic attack 1-6 months before randomization. Antihypertensive and statin treatments will be initiated or modified using suitable registered agents chosen by the investigators, in order to maintain patients within the randomized SBP and LDL-C windows. All patients will be followed up every 3 months for BP and every 6 months for LDL-C. Ambulatory BP will be measured yearly. OUTCOMES: Primary outcome is time to stroke (fatal and non-fatal). Important secondary outcomes are: time to first major cardiovascular event; cognitive decline (Montreal Cognitive Assessment) and dementia. All major outcomes will be adjudicated by committees blind to randomized allocation. A Data and Safety Monitoring Board has open access to data and can recommend trial interruption for safety. SAMPLE SIZE CALCULATION: It has been calculated that 925 patients would reach the primary outcome after a mean 4-year follow-up, and this should provide at least 80% power to detect a 25% stroke difference between SBP targets and a 20% difference between LDL-C targets.